Jane Street Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $72.9 Billion
- Q1 2024
A detailed history of Jane Street Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 128,072 shares of ARWR stock, worth $3.68 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
128,072
Previous 83,031
54.25%
Holding current value
$3.68 Million
Previous $2.54 Million
44.17%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
88.2MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$441 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$357 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$246 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$189 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$119 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.04B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...